中文文献

1. 中国中西医结合学会皮肤性病专业委员会. (2021). 《细菌性皮肤感染诊疗专家共识》. 中华皮肤科杂志, 54(6), 471-476.

- DOI: 10.35541/cjd.20210121

*（明确多黏菌素B在革兰氏阴性菌感染性溃疡及烧伤创面中的应用）*

2. 张伟, 李华. (2019). 《多黏菌素B联合用药治疗复杂性皮肤感染的临床观察》. 中国感染与化疗杂志, 19(3), 289-293.

*（探讨复方制剂“多黏菌素B+新霉素”对混合感染性湿疹的疗效）*

3. 中华医学会烧伤外科学分会. (2018). 《烧伤创面感染防治指南》. 中华烧伤杂志, 34(5), 272-278.

*（推荐多黏菌素B软膏用于铜绿假单胞菌感染的烧伤创面）*

---

英文文献

4. Elston, D. M. (2020). *Gram-negative bacterial infections of the skin*. In: *Fitzpatrick’s Dermatology* (10th ed., pp. 2897-2905). McGraw-Hill.

5. Rao, G. G., et al. (2021). *Topical polymyxin B in the management of multidrug-resistant Pseudomonas aeruginosa wound infections*. *Journal of Antimicrobial Chemotherapy*, 76(8), 2034-2040.

- DOI: 10.1093/jac/dkab149

6. Wong, S. Y., et al. (2019). *Combination topical antibiotics for infected dermatitis: A randomized controlled trial*. *British Journal of Dermatology*, 181(5), 987-994.

- DOI: 10.1111/bjd.17823

*（复方制剂“多黏菌素B+杆菌肽”在混合感染性皮炎中的疗效评估）*

7. Patel, J. B., et al. (2017). *Performance standards for antimicrobial susceptibility testing* (27th ed.). CLSI Supplement M100. Clinical and Laboratory Standards Institute.

*（实验室指南：多黏菌素B对革兰氏阴性菌的敏感性与耐药性数据）*

---

国际指南

8. World Health Organization (WHO). (2022). *WHO guidelines on the use of topical antibiotics in skin infections*. Geneva: WHO Press.

- ISBN: 978-92-4-005602-5

*（建议限制多黏菌素B滥用以减缓耐药性发展）*

9. European Dermatology Forum (EDF). (2020). *Evidence-based guidelines for the management of bacterial skin infections*. *Journal of the European Academy of Dermatology and Venereology*, 34(Suppl 4), 1-30.

- DOI: 10.1111/jdv.16789

*（明确多黏菌素B不适用于痤疮或单纯革兰氏阳性菌感染）*